Skip to the page

Data / Form D filings / Liberation Bioindustries, Inc.

Liberation Bioindustries, Inc.: Form D filings

Liberation Bioindustries, Inc., a technology company in New York, NY, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on December 10, 2025, reports $60.2 million sold of a $101.7 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
14 Wall Street, 20th Floor, New York, NY, 10005
Phone
(917) 539-8620
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1952448

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 10, 2025New notice$101,664,354$60,164,351$41,500,0037Nov 24, 2025sec.gov
Feb 10, 2025New notice$51,982,971$51,982,9716Jan 28, 2025sec.gov
Oct 28, 2022New notice$20,000,000$9,100,009$10,899,9914Oct 19, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Philip BoignerDirector
James MellonDirector
Etan BendheimExecutive Officer
Mark WarnerExecutive Officer, Director
Babar KhanDirector
Steven FinnDirector

Other technology companies in New York that filed recently

Every Form D from the week of Dec 8, 2025 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Liberation Bioindustries, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.